Login / Signup

Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics.

Taralynn M MackCaitlyn VlasschaertKelly von BeckAlexander James SilverJonathan Brett HeimlichHannah M PoisnerHenry Robert CondonJessica UlloaAndrew L SochackiTravis P SpauldingAshwin KishtagariCosmin A BejanYaomin XuMichael R SavonaAngela JonesAlexander G Bick
Published in: medRxiv : the preprint server for health sciences (2023)
Clonal hematopoiesis of indeterminate potential (CHIP) is a common age-related phenomenon that occurs when hematopoietic stem cells acquire mutations in a select set of genes commonly mutated in myeloid neoplasia which then expand clonally. Current sequencing assays to detect CHIP are not optimized for the detection of these variants and can be cost-prohibitive when applied to large cohorts or serial sequencing. Here, we present and validate a CHIP targeted sequencing assay that is affordable (∼$8/sample), accurate and highly scalable. To demonstrate the utility of this assay, we detected CHIP in a cohort of 456 individuals with DNA collected at multiple timepoints in the Vanderbilt BioVU biobank and quantified clonal expansion rates over time. A total of 101 individuals with CHIP were identified, and individual-level clonal expansion rate was calculated using the variant allele fraction (VAF) at both timepoints. Differences in clonal expansion rate by driver gene were observed, but there was also significant individual-level heterogeneity, emphasizing the multifactorial nature of clonal expansion. We further describe the mutation co-occurrence and clonal competition between multiple driver mutations.
Keyphrases